InMed Pharmaceuticals Inc. Quarterly Employee-related Liabilities, Current in USD from Q2 2022 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Summary
InMed Pharmaceuticals Inc. quarterly Employee-related Liabilities, Current history and growth rate from Q2 2022 to Q4 2023.
  • InMed Pharmaceuticals Inc. Employee-related Liabilities, Current for the quarter ending December 31, 2023 was $102K.
Employee-related Liabilities, Current, Quarterly (USD)
Employee-related Liabilities, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $102K Dec 31, 2023 10-Q 2024-02-13
Q3 2023 $280K Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $542K +$403K +290% Jun 30, 2023 10-Q 2023-11-14
Q2 2022 $139K Jun 30, 2022 10-K 2023-09-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.